World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
75
Citations
19418
World Ranking
5333
National Ranking
413

Overview

Peter H. Sugden is affiliated with the University of Reading in the United Kingdom. Their research primarily focuses on the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these broad areas, the subfields of Molecular Biology and Cardiology and Cardiovascular Medicine are prominently represented in their work, alongside smaller contributions to Organic Chemistry, Oncology, and Pathology and Forensic Medicine.

The scientist's notable research topics include:

  • Melanoma and MAPK Pathways
  • Cardiac Fibrosis and Remodeling
  • Protein Kinase Regulation and GTPase Signaling
  • Receptor Mechanisms and Signaling
  • Redox biology and oxidative stress
  • Heat shock proteins research
  • Genomics, phytochemicals, and oxidative stress

Frequent collaborators in their research include Angela Clerk, Joshua J. Cull, Susanna T.E. Cooper, Hajed Obaid Alharbi, and Stephen J. Fuller, reflecting a network of coauthors with multiple joint publications.

Their recent research publications demonstrate sustained activity in cardiovascular and biochemical research areas. These include:

  • "Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension," 2020, published in Hypertension
  • "The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension," 2021, published in Clinical Science
  • "The insulin receptor family and protein kinase B (Akt) are activated in the heart by alkaline pH and α1-adrenergic receptors," 2021, published in Biochemical Journal
  • "MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins," 2021, published in Biochemical Journal
  • "The insulin receptor family in the heart: new light on old insights," 2022, published in Bioscience Reports

Their most frequent publication venues include Clinical Science, Biochemical Journal, bioRxiv (Cold Spring Harbor Laboratory), Hypertension, and Bioscience Reports, showing a focus on journals related to experimental and clinical biomedical research.

Best Publications

  • Stimulation of the Stress-Activated Mitogen-Activated Protein Kinase Subfamilies in Perfused Heart: p38/RK Mitogen-Activated Protein Kinases and c-Jun N-Terminal Kinases Are Activated by Ischemia/Reperfusion

    Marie A. Bogoyevitch;Judith Gillespie-Brown;Albert J. Ketterman;Stephen J. Fuller

  • “Stress-Responsive” Mitogen-Activated Protein Kinases (c-Jun N-Terminal Kinases and p38 Mitogen-Activated Protein Kinases) in the Myocardium

    Peter H. Sugden;Angela Clerk

  • Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy.

    M A Bogoyevitch;P E Glennon;M B Andersson;Angela Clerk

  • Cellular mechanisms of cardiac hypertrophy

    P. H. Sugden;Angela Clerk

  • Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.

    Thomas Eschenhagen;Thomas Force;Michael S. Ewer;Gilles W. De Keulenaer

  • Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors.

    Peter H Sugden;Angela Clerk

  • Compartmentalization of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in heart tissue.

    J D Corbin;P H Sugden;T M Lincoln;S L Keely

  • Stimulation of “Stress-regulated” Mitogen-activated Protein Kinases (Stress-activated Protein Kinases/c-Jun N-terminal Kinases and p38-Mitogen-activated Protein Kinases) in Perfused Rat Hearts by Oxidative and Other Stresses

    Angela Clerk;Stephen J. Fuller;Ashour Michael;Peter H. Sugden

  • Stimulation of the p38 Mitogen-activated Protein Kinase Pathway in Neonatal Rat Ventricular Myocytes by the G Protein–coupled Receptor Agonists, Endothelin-1 and Phenylephrine: A Role in Cardiac Myocyte Hypertrophy?

    Angela Clerk;Ashour Michael;Peter H. Sugden

  • Purification and characterization of the catalytic subunit of adenosine 3':5'-cyclic monophosphate-dependent protein kinase from bovine liver.

    P H Sugden;L A Holladay;E M Reimann;J D Corbin

  • Phenotyping Hypertrophy Eschew Obfuscation

    Gerald W. Dorn;Jeffrey Robbins;Peter H. Sugden

  • Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts.

    Angela Clerk;M A Bogoyevitch;M B Anderson;P H Sugden

  • Characterization of protein kinase C isotype expression in adult rat heart. Protein kinase C-epsilon is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin.

    M A Bogoyevitch;P J Parker;P H Sugden

  • Regulation of Bcl-2 Family Proteins During Development and in Response to Oxidative Stress in Cardiac Myocytes Association With Changes in Mitochondrial Membrane Potential

    Stuart A. Cook;Peter H. Sugden;Angela Clerk

  • Depletion of Mitogen-Activated Protein Kinase Using an Antisense Oligodeoxynucleotide Approach Downregulates the Phenylephrine-Induced Hypertrophic Response in Rat Cardiac Myocytes

    Peter E. Glennon;Samer Kaddoura;Elizabeth M. Sale;Graham J. Sale

  • Signaling in myocardial hypertrophy: life after calcineurin?

    Peter H. Sugden

  • Insulin-like Growth Factor-I Rapidly Activates Multiple Signal Transduction Pathways in Cultured Rat Cardiac Myocytes

    Rocı́o Foncea;Monica Andersson;Albert Ketterman;Vicky Blakesley

  • Cellular Stresses Differentially Activate c-Jun N-terminal Protein Kinases and Extracellular Signal-regulated Protein Kinases in Cultured Ventricular Myocytes

    Marie A. Bogoyevitch;Albert J. Ketterman;Peter H. Sugden

  • The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)

    Angela Clerk;Peter H Sugden

  • Regulation of protein turnover in skeletal and cardiac muscle.

    P H Sugden;S J Fuller

Frequent Co-Authors

Angela Clerk
Angela Clerk University of Reading
Marie A. Bogoyevitch
Marie A. Bogoyevitch University of Melbourne
Stuart A. Cook
Stuart A. Cook Duke NUS Graduate Medical School
Christopher J. Marshall
Christopher J. Marshall Institute of Cancer Research
Hugh Paterson
Hugh Paterson Institute of Cancer Research
Philip A. Poole-Wilson
Philip A. Poole-Wilson National Institutes of Health
Jeffery D. Molkentin
Jeffery D. Molkentin Cincinnati Children's Hospital Medical Center
Peter J. Parker
Peter J. Parker The Francis Crick Institute
Sergio Lavandero
Sergio Lavandero University of Chile
Richard Marais
Richard Marais University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Peter H. Sugden

Trending Scientists

Recently Published Articles